Journey Medical Corporation Common Stock (DERM) is a publicly traded Healthcare sector company. As of November 5, 2026, DERM trades at $4.75 with a market cap of $130.96M and a P/E ratio of -27.39. DERM moved +0.32% today. Year to date, DERM is -33.36%; over the trailing twelve months it is -47.28%. Its 52-week range spans $4.31 to $9.56. Analyst consensus is buy with an average price target of $13.50. Rallies surfaces DERM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for DERM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $4.75 |
| Market Cap | $130.96M |
| P/E Ratio | -27.39 |
| EPS | $-0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.56 |
| 52-Week Low | $4.31 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $68.18M |
| Net Income | $-6.10M |
| Gross Margin | 65.45% |
2 analysts cover DERM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.50.